BG106190A - Method for the preparation of citalopram - Google Patents

Method for the preparation of citalopram

Info

Publication number
BG106190A
BG106190A BG106190A BG10619001A BG106190A BG 106190 A BG106190 A BG 106190A BG 106190 A BG106190 A BG 106190A BG 10619001 A BG10619001 A BG 10619001A BG 106190 A BG106190 A BG 106190A
Authority
BG
Bulgaria
Prior art keywords
citalopram
preparation
compound
isolation
reaction
Prior art date
Application number
BG106190A
Other languages
Bulgarian (bg)
English (en)
Inventor
Hans Petersen
Michael Rock
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of BG106190A publication Critical patent/BG106190A/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2282Unsaturated compounds used as ligands
    • B01J31/2295Cyclic compounds, e.g. cyclopentadienyls
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/42Catalytic cross-coupling, i.e. connection of previously not connected C-atoms or C- and X-atoms without rearrangement
    • B01J2231/4205C-C cross-coupling, e.g. metal catalyzed or Friedel-Crafts type
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84Metals of the iron group
    • B01J2531/847Nickel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
BG106190A 1999-06-25 2001-12-07 Method for the preparation of citalopram BG106190A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900921 1999-06-25
PCT/DK1999/000643 WO2000011926A2 (en) 1999-06-25 1999-11-19 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
BG106190A true BG106190A (en) 2002-08-30

Family

ID=8099044

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106190A BG106190A (en) 1999-06-25 2001-12-07 Method for the preparation of citalopram

Country Status (36)

Country Link
US (1) US6750358B2 (ko)
EP (1) EP1105382B1 (ko)
JP (1) JP3389571B2 (ko)
KR (1) KR100491369B1 (ko)
CN (1) CN1129593C (ko)
AR (1) AR020573A1 (ko)
AT (3) AT409960B (ko)
AU (2) AU2001100433B4 (ko)
BG (1) BG106190A (ko)
BR (1) BR9917367A (ko)
CA (1) CA2290125C (ko)
CH (1) CH691304A5 (ko)
CZ (1) CZ292174B6 (ko)
DE (2) DE69900891D1 (ko)
DK (1) DK1105382T3 (ko)
EA (1) EA002661B1 (ko)
ES (1) ES2172356T3 (ko)
FI (1) FI108538B (ko)
GB (1) GB2354240B (ko)
HK (1) HK1047745B (ko)
HU (1) HUP0103417A3 (ko)
IL (1) IL145960A0 (ko)
IS (1) IS5862A (ko)
IT (1) ITMI991579A1 (ko)
MX (1) MXPA01010986A (ko)
NO (1) NO20010318L (ko)
NZ (1) NZ514982A (ko)
PL (1) PL345971A1 (ko)
PT (1) PT1105382E (ko)
SE (1) SE516689C2 (ko)
SI (1) SI1105382T1 (ko)
SK (1) SK18412001A3 (ko)
TR (1) TR200103700T2 (ko)
UA (1) UA62023C2 (ko)
WO (1) WO2000011926A2 (ko)
ZA (1) ZA200108855B (ko)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
PT1173431E (pt) 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EA002801B1 (ru) 1999-10-25 2002-10-31 Х.Лундбекк А/С Способ получения циталопрама
CH692421A5 (de) 1999-10-25 2002-06-14 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram.
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
NZ519739A (en) 1999-12-28 2004-03-26 H Method for the preparation of citalopram
MXPA02006504A (es) 1999-12-30 2002-12-09 Lundbeck & Co As H Metodo para la preparacion de citalopram.
MXPA02006915A (es) 2000-01-14 2002-10-23 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida.
FR2805812A1 (fr) 2000-02-24 2001-09-07 Lundbeck & Co As H Procede de preparation du citalopram
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
TR200202166T2 (tr) 2000-03-13 2002-12-23 H. Lndbeck A/S Sitalopramın preparasyon metodu
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
AU2001239213A1 (en) 2000-03-14 2001-09-24 H Lundbeck A/S Method for the preparation of citalopram
MXPA02008652A (es) * 2000-03-16 2003-02-24 Lundbeck & Co As H Metodo para la preparacion de 5-ciano-1-(4-fluorofenil)-1,3-dihidroisobenzofuranos.
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
BR0106976A (pt) * 2000-07-06 2002-07-23 Lundbeck & Co As H Método para a preparação de citalopram
FI20011621A (fi) * 2000-08-18 2002-02-19 Lundbeck & Co As H Menetelmä sitalopraamin valmistamiseksi
DK1181713T3 (da) 2000-12-22 2005-01-31 Lundbeck & Co As H Fremgangsmåde til fremstilling af rent citalopram
AU2001100399B4 (en) * 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram
EP1355897A1 (en) 2001-01-30 2003-10-29 Orion Corporation Fermion Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
JP2005500256A (ja) * 2001-03-09 2005-01-06 ランバクシー ラボラトリーズ リミテッド シタロプラム製造方法
CN1660074A (zh) 2001-07-31 2005-08-31 H·隆德贝克有限公司 含有依他普仑的晶体组合物
AU2003222435A1 (en) 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
JP2006008603A (ja) * 2004-06-25 2006-01-12 Sumitomo Chemical Co Ltd 光学活性シタロプラムの製造方法、その中間体およびその製造方法
DE05815687T1 (de) 2004-08-23 2007-10-18 Sun Pharmaceutical Industries Ltd. Verfahren zur herstellung von citalopram und enantiomeren
WO2006103550A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Processes for the preparation of citalopram and its intermediate 5-aminophthalide
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (ko) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
CA2010159A1 (en) 1989-02-21 1990-08-21 James J. Maul Cyanation of haloaromatics utilizing catalysts generated in situ starting with nic1 or nic1 6h 0
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19706648A1 (de) 1997-02-20 1998-08-27 Bayer Ag Verfahren zur Herstellung von aromatischen Nitrilen
KR100357975B1 (ko) 1997-07-08 2002-10-25 하. 룬트벡 아크티에 셀스카브 시탈로프램의 제조방법
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
JP3813820B2 (ja) 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
BR9915158B1 (pt) 1998-10-20 2012-02-22 método para preparação de citalopram, e, compostos da fórmula geral viii, ix e iv, ou qualquer de seus enantiÈmeros e sais com adição de ácido do mesmo.
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
DE10015280A1 (de) 1999-03-29 2001-01-04 Nissan Chemical Ind Ltd Verfahren zur Herstellung von Benzonitrilverbindungen
PT1173431E (pt) 1999-04-14 2003-09-30 Lundbeck & Co As H Metodo de preparacao do citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
CH692421A5 (de) 1999-10-25 2002-06-14 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram.
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
DK1181713T3 (da) 2000-12-22 2005-01-31 Lundbeck & Co As H Fremgangsmåde til fremstilling af rent citalopram
AU2001100399B4 (en) 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram

Also Published As

Publication number Publication date
KR100491369B1 (ko) 2005-05-24
ZA200108855B (en) 2002-08-28
EP1105382A2 (en) 2001-06-13
US6750358B2 (en) 2004-06-15
SK18412001A3 (sk) 2002-05-09
NZ514982A (en) 2004-01-30
AT4366U1 (de) 2001-06-25
NO20010318L (no) 2001-02-20
ATE213237T1 (de) 2002-02-15
JP3389571B2 (ja) 2003-03-24
AU2001100433B4 (en) 2002-01-17
CA2290125A1 (en) 2000-12-25
ITMI991579A1 (it) 2001-01-15
AR020573A1 (es) 2002-05-15
GB2354240B (en) 2001-05-23
DE19983486T1 (de) 2001-10-18
MXPA01010986A (es) 2002-06-04
HK1047745B (zh) 2004-09-10
WO2000011926A3 (en) 2000-06-29
AT409960B (de) 2002-12-27
SE0100194L (sv) 2001-04-25
CN1356993A (zh) 2002-07-03
GB2354240A (en) 2001-03-21
CH691304A5 (de) 2001-06-29
JP2002523432A (ja) 2002-07-30
UA62023C2 (en) 2003-12-15
AU1374800A (en) 2000-03-21
HK1047745A1 (en) 2003-03-07
TR200103700T2 (tr) 2002-05-21
AU2001100433A4 (en) 2001-11-01
IL145960A0 (en) 2002-07-25
CZ292174B6 (cs) 2003-08-13
IS5862A (is) 2001-02-23
BR9917367A (pt) 2002-03-05
ATA904099A (de) 2002-05-15
FI108538B (fi) 2002-02-15
ES2172356T3 (es) 2002-09-16
HUP0103417A3 (en) 2003-01-28
SE516689C2 (sv) 2002-02-12
EA002661B1 (ru) 2002-08-29
DE19983486C2 (de) 2002-09-05
DK1105382T3 (da) 2002-05-27
EA200101071A1 (ru) 2002-02-28
HUP0103417A2 (hu) 2002-01-28
PL345971A1 (en) 2002-01-14
PT1105382E (pt) 2002-07-31
EP1105382B1 (en) 2002-02-13
CZ2001319A3 (en) 2001-05-16
CN1129593C (zh) 2003-12-03
GB0101508D0 (en) 2001-03-07
FI20010154A (fi) 2001-02-09
SI1105382T1 (en) 2002-06-30
NO20010318D0 (no) 2001-01-19
US20020061925A1 (en) 2002-05-23
CA2290125C (en) 2004-08-10
SE0100194D0 (sv) 2001-01-24
KR20020011982A (ko) 2002-02-09
WO2000011926A2 (en) 2000-03-09
DE69900891D1 (de) 2002-03-21
ITMI991579A0 (it) 1999-07-15

Similar Documents

Publication Publication Date Title
BG106190A (en) Method for the preparation of citalopram
ZA200200922B (en) Method for reacting an organic compound with a hydroperoxide.
GB2354239A (en) Method for the preparation of citalopram
AU9538598A (en) Catalyst comprising at least one phosphonite ligand based nickel (o) complex andmethod for the production of nitriles
EP1156042A4 (en) PROCESS FOR THE PREPARATION OF GLYCEROL CARBONATE
IL150367A0 (en) Method for the preparation of citalopram
MXPA00012863A (es) Proceso para la preparacion de 3-aril-benzofuranonas.
EP0714900A3 (de) Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung
BG106002A (en) Process for preparing pesticidal intermediates
MXPA03011401A (es) Procedimiento para la preparacion de derivados de ciclohexanol.
BG107048A (en) Method for the preparation of citalopram
ZA993902B (en) Process and intermediates for the manufacture of pyridine-2,3-dicarboxylate compounds.
PL343546A1 (en) Processes for preparing intermediates
IL137027A0 (en) A process for the preparation of cyclopropane carboxylic acids
GB2414731A (en) Process for preparing diltiazem using a heterogeneous trifunctional catalyst
CZ20011520A3 (cs) Způsob výroby alfa-arylalkanových kyselin
BG104486A (en) Method for the preparation of citalopram
ZA9710343B (en) Utilization of an egg-based preparation as an antidepressant.
UA36367A (uk) Кальцію сукцинат, що має кардіотонічну дію
BG102318A (en) Epoxy-azetidinons, their preparation and application
MXPA04004708A (es) Proceso para preparacion de 2- o 9-oxa-3,7-diazabiciclo (3.3.1)nonanos a partir de 2-aminometil-2,3-dihidrooxazinas, compuestos intermedios para los mismos y proceso para preparar tales compuestos intermedios.